HomeCompareATNF vs NNN

ATNF vs NNN: Dividend Comparison 2026

ATNF yields 28.41% · NNN yields 5.66%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ATNF wins by $95.2K in total portfolio value
10 years
ATNF
ATNF
● Live price
28.41%
Share price
$7.04
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$120.7K
Annual income
$15,231.92
Full ATNF calculator →
NNN
NNN REIT Inc.
● Live price
5.66%
Share price
$42.03
Annual div
$2.38
5Y div CAGR
8.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$25.5K
Annual income
$2,622.67
Full NNN calculator →

Portfolio growth — ATNF vs NNN

📍 ATNF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodATNFNNN
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ATNF + NNN cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ATNF pays
NNN pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ATNF
Annual income on $10K today (after 15% tax)
$2,414.77/yr
After 10yr DRIP, annual income (after tax)
$12,947.13/yr
NNN
Annual income on $10K today (after 15% tax)
$481.32/yr
After 10yr DRIP, annual income (after tax)
$2,229.27/yr
At 15% tax rate, ATNF beats the other by $10,717.86/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ATNF + NNN for your $10,000?

ATNF: 50%NNN: 50%
100% NNN50/50100% ATNF
Portfolio after 10yr
$73.1K
Annual income
$8,927.30/yr
Blended yield
12.21%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on NNN right now

ATNF
Analyst Ratings
1
Hold
Consensus: Hold
Altman Z
-2.9
Piotroski
3/9
NNN
Analyst Ratings
10
Buy
15
Hold
4
Sell
Consensus: Hold
Price Target
$44.93
+6.9% upside vs current
Range: $43.00 — $48.50
Altman Z
1.1
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ATNF buys
0
NNN buys
0
No recent congressional trades found for ATNF or NNN in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricATNFNNN
Forward yield28.41%5.66%
Annual dividend / share$2.00$2.38
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%8.6%
Portfolio after 10y$120.7K$25.5K
Annual income after 10y$15,231.92$2,622.67
Total dividends collected$80.6K$13.7K
Payment frequencyquarterlyquarterly
SectorStockREIT
Analyst consensusHoldHold

Year-by-year: ATNF vs NNN ($10,000, DRIP)

YearATNF PortfolioATNF Income/yrNNN PortfolioNNN Income/yrGap
1← crossover$13,541$2,840.91$10,735$614.96+$2.8KATNF
2$18,084$3,595.19$11,572$708.43+$6.5KATNF
3$23,837$4,487.28$12,531$819.53+$11.3KATNF
4$31,034$5,527.89$13,633$952.29+$17.4KATNF
5$39,932$6,725.96$14,909$1,111.84+$25.0KATNF
6$50,815$8,088.33$16,392$1,304.77+$34.4KATNF
7$63,992$9,619.46$18,129$1,539.52+$45.9KATNF
8$79,793$11,321.31$20,173$1,827.08+$59.6KATNF
9$98,572$13,193.22$22,597$2,181.81+$76.0KATNF
10$120,703$15,231.92$25,491$2,622.67+$95.2KATNF

ATNF vs NNN: Complete Analysis 2026

ATNFStock

1180 Life Sciences Corp., a clinical-stage biotechnology company, develops therapeutics for unmet medical needs in chronic pain, inflammation, fibrosis, and other inflammatory diseases. Its product development platforms include fibrosis and anti-tumor necrosis factor (anti-TNF) platform, which is under Phase IIb clinical trials that focuses on fibrosis and Anti-TNF; Synthetic Cannabidiol (CBD) Analogs platform, which is under preclinical trials that are man-made derivatives of CBD; and a7nAChR platform, an immune suppressive, which is under preclinical trails that focuses on alpha 7 nicotinic acetylcholine receptor. The company was incorporated in 2016 and is headquartered in Palo Alto, California.

Full ATNF Calculator →

NNNREIT

National Retail Properties invests primarily in high-quality retail properties subject generally to long-term, net leases. As of September 30, 2020, the company owned 3,114 properties in 48 states with a gross leasable area of approximately 32.4 million square feet and with a weighted average remaining lease term of 10.7 years.

Full NNN Calculator →
📬

Get this ATNF vs NNN comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ATNF vs SCHDATNF vs JEPIATNF vs OATNF vs KOATNF vs MAINATNF vs ADCATNF vs EPRTATNF vs FCPT

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.